Gray Sheds Light on Considerations When Treating NSCLC With Immunotherapy – Targeted Oncology
Targeted Oncology |
Gray Sheds Light on Considerations When Treating NSCLC With Immunotherapy
Targeted Oncology Jhanelle E. Gray, MD, recently shared the treatment considerations and decisions she makes when treating patients with non–small cell lung cancer (NSCLC), with a special focus on immunotherapy. Gray, associate member, Director of Thoracic Clinical … |
